Another way, STAT3 promotes a pro-proliferative PASMC phenotype found in PAH patients is by increasing PIM1 gene expression and Nuclear Factor of Activated T Cells 2 (NFATC2) activity (183, 185). The gene discussed is PIM1; the disease is pulmonary arterial hypertension.